Calimbayan, Khate .
HRN: 26-63-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
CEFUROXIME 1.5GM (VIAL)
02/02/2025
02/08/2025
IVT
467mg
Q8hours
Kawasaki Disease
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes